Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years.
R&D Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US
R&D Heard on the pipeline: R&D in the pharma industry In the fast-paced world of healthcare, it can take a lot of work to keep up-to-date with the numerous innovations, trends, and opinions that emerge each year.
R&D What’s next for oncology research? Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023.
R&D Plotting the way forward on clinical trial diversity As the old adage goes, the first step towards solving a problem is admitting you have one.
R&D Into the bowels of gut research For people living with Inflammatory Bowel Disease (IBD), navigating life around the risk of flare-ups can be a messy and exhausting challenge.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
